2020 Q1 Form 10-Q Financial Statement

#000107997320000092 Filed on February 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2018 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $268.8K $387.5K $289.6K
YoY Change -11.92% 33.82% -64.25%
% of Gross Profit
Research & Development $135.1K $114.5K $114.2K
YoY Change 30.45% 0.23% -66.29%
% of Gross Profit
Depreciation & Amortization $347.00 $347.00 $259.00
YoY Change 28.04% 33.98% -40.6%
% of Gross Profit
Operating Expenses $404.2K $502.3K $404.1K
YoY Change -1.16% 24.32% -64.8%
Operating Profit -$404.2K -$502.3K -$404.1K
YoY Change -1.16% 24.32% -64.8%
Interest Expense $103.1K $142.7K $97.30K
YoY Change 2.79% 46.69% 3.89%
% of Operating Profit
Other Income/Expense, Net -$103.1K -$142.7K -$97.30K
YoY Change 2.79% 46.69% -115.57%
Pretax Income -$507.3K -$645.1K -$501.3K
YoY Change -0.38% 28.67% -3.59%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$507.3K -$645.1K -$501.4K
YoY Change -0.38% 28.66% -4.11%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$17.10K -$22.37K -$18.98K
COMMON SHARES
Basic Shares Outstanding 29.54M
Diluted Shares Outstanding 29.64M 28.80M 26.38M

Balance Sheet

Concept 2020 Q1 2019 Q4 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $356.6K $469.2K $42.32K
YoY Change 139.07% 1008.6% 41.07%
Cash & Equivalents $356.6K $469.2K $42.32K
Short-Term Investments
Other Short-Term Assets $4.980K $1.000K $2.610K
YoY Change -3.49% -61.69%
Inventory
Prepaid Expenses $3.983K $1.608K
Receivables
Other Receivables $1.000K $1.000K $1.000K
Total Short-Term Assets $361.6K $470.2K $44.93K
YoY Change 134.3% 946.46% 48.91%
LONG-TERM ASSETS
Property, Plant & Equipment $1.575K $1.922K $1.711K
YoY Change -46.86% 12.33% -26.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.575K $1.922K $1.711K
YoY Change -46.86% 12.33% -65.06%
TOTAL ASSETS
Total Short-Term Assets $361.6K $470.2K $44.93K
Total Long-Term Assets $1.575K $1.922K $1.711K
Total Assets $363.2K $472.1K $46.64K
YoY Change 130.89% 912.19% 33.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $719.9K $701.3K $643.7K
YoY Change 7.05% 8.95% -30.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $9.506M $9.445M $9.160M
YoY Change 3.01% 3.1% 2.81%
Total Short-Term Liabilities $10.91M $10.72M $10.54M
YoY Change 1.26% 1.73% 4.84%
LONG-TERM LIABILITIES
Long-Term Debt $4.560M $4.523M $3.588M
YoY Change 25.98% 26.06% 3.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.560M $4.523M $3.588M
YoY Change 25.98% 26.06% 3.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.91M $10.72M $10.54M
Total Long-Term Liabilities $4.560M $4.523M $3.588M
Total Liabilities $15.47M $15.24M $14.12M
YoY Change 7.47% 7.91% 4.49%
SHAREHOLDERS EQUITY
Retained Earnings -$126.1M -$125.6M -$123.1M
YoY Change 1.96% 1.97% 2.85%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.16M -$14.82M -$14.13M
YoY Change
Total Liabilities & Shareholders Equity $363.2K $472.1K $46.64K
YoY Change 130.89% 912.19% 33.0%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2018 Q4
OPERATING ACTIVITIES
Net Income -$507.3K -$645.1K -$501.4K
YoY Change -0.38% 28.66% -4.11%
Depreciation, Depletion And Amortization $347.00 $347.00 $259.00
YoY Change 28.04% 33.98% -40.6%
Cash From Operating Activities -$276.4K -$325.8K -$191.7K
YoY Change 39.83% 69.99% 59.72%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 163.8K 720.3K 52.93K
YoY Change -46.47% 1260.93% -62.19%
NET CHANGE
Cash From Operating Activities -276.4K -325.8K -191.7K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 163.8K 720.3K 52.93K
Net Change In Cash -112.6K 394.5K -138.7K
YoY Change -206.29% -384.39% -793.65%
FREE CASH FLOW
Cash From Operating Activities -$276.4K -$325.8K -$191.7K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$276.4K -$325.8K -$191.7K
YoY Change 41.61% 69.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
166776
bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
222300
bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
35339
bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2019Q4 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
173245
CY2019Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
173245
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
71658
bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
100000
bnet Conversion Of Deferred Compensation Into Note Payable Affiliate
ConversionOfDeferredCompensationIntoNotePayableAffiliate
636081
bnet Conversion Of Deferred Compensation Into Note Payable Affiliate
ConversionOfDeferredCompensationIntoNotePayableAffiliate
bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on such accounts.</div></div></div></div></div></div></div></div></div></div></div></div>
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
BION ENVIRONMENTAL TECHNOLOGIES INC
dei Entity Central Index Key
EntityCentralIndexKey
0000875729
dei Trading Symbol
TradingSymbol
bnet
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29540696
dei Entity Shell Company
EntityShellCompany
false
CY2013Q2 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
CY2019Q4 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2019Q4 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9444576
CY2019Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9303270
bnet Loans Payable To Affiliates
LoansPayableToAffiliates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;LOANS PAYABLE - AFFILIATES:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>Dominic Bassani (&#x201c;Bassani&#x201d;), the Company&#x2019;s Chief Executive Officer, and Mark A. Smith (&#x201c;Smith&#x201d;), the Company&#x2019;s President, loaned the Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,000,</div> respectively, for working capital needs. The loans were non-interest bearing and Bassani&#x2019;s loan was repaid in cash, while Smith&#x2019;s loan was converted into units of the Company at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div> per unit, with each unit consisting of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of the Company&#x2019;s restricted common stock and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of the Company&#x2019;s restricted common stock for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.75</div> per share until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2020.</div></div></div>
bnet Modification Of Warrants
ModificationOfWarrants
35339
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
977000
bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
477365
bnet Sale Of Units Value
SaleOfUnitsValue
477365
bnet Sale Of Units Value
SaleOfUnitsValue
977000
CY2019Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2018Q4 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
44436
bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
87200
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
4850
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
330000
bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
0.84
CY2019Q4 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
1090714
CY2018Q4 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
90939
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
771030
bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
785681
bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P2Y292D
CY2019Q4 bnet Working Capital
WorkingCapital
-10247000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
701299
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
715554
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2795463
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794769
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
111239449
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110126802
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
118000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
99500
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6250
CY2019Q4 us-gaap Assets
Assets
472086
CY2019Q2 us-gaap Assets
Assets
52956
CY2019Q4 us-gaap Assets Current
AssetsCurrent
470164
CY2019Q2 us-gaap Assets Current
AssetsCurrent
50340
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2019Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2019Q2 us-gaap Cash
Cash
41335
CY2018Q2 us-gaap Cash
Cash
22013
CY2019Q4 us-gaap Cash
Cash
469164
CY2018Q4 us-gaap Cash
Cash
42321
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
427829
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
20308
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
740551
CY2019Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2019Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30195005
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28068688
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28417602
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26996148
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25939892
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29490696
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27364379
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27713293
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26291839
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25235583
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2019Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
4523210
CY2019Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3801168
CY2019Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
537119
CY2018Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
698766
CY2019Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
874162
CY2019Q4 us-gaap Depreciation
Depreciation
347
CY2018Q4 us-gaap Depreciation
Depreciation
259
us-gaap Depreciation
Depreciation
694
us-gaap Depreciation
Depreciation
695
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
387526
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
289599
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
707754
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
967489
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
38575
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62989
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
288204
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
355800
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8005
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5866
CY2019Q4 us-gaap Interest Expense
InterestExpense
142738
CY2018Q4 us-gaap Interest Expense
InterestExpense
97304
us-gaap Interest Expense
InterestExpense
260340
us-gaap Interest Expense
InterestExpense
189800
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q4 us-gaap Liabilities
Liabilities
15240604
CY2019Q2 us-gaap Liabilities
Liabilities
14727554
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
472086
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52956
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10717394
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10926386
CY2019Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2019Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2019Q4 us-gaap Minority Interest
MinorityInterest
48135
CY2019Q2 us-gaap Minority Interest
MinorityInterest
49408
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
904800
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
432929
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-958
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-476971
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-411663
CY2019Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-768
CY2018Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-523
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1273
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3692
CY2019Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-644297
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-500831
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1205294
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1438205
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-142738
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-97304
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-260340
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-189800
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
502327
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
404050
us-gaap Operating Expenses
OperatingExpenses
946227
us-gaap Operating Expenses
OperatingExpenses
1252097
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-502327
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-404050
us-gaap Operating Income Loss
OperatingIncomeLoss
-946227
us-gaap Operating Income Loss
OperatingIncomeLoss
-1252097
us-gaap Other Noncash Expense
OtherNoncashExpense
278268
us-gaap Other Noncash Expense
OtherNoncashExpense
203632
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2019Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
87200
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
44436
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
958
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8005
CY2019 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
897000
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
418000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
977000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
35000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2019 us-gaap Profit Loss
ProfitLoss
-2659000
CY2018 us-gaap Profit Loss
ProfitLoss
-3018000
us-gaap Profit Loss
ProfitLoss
-1206567
us-gaap Profit Loss
ProfitLoss
-1441897
CY2019Q4 us-gaap Profit Loss
ProfitLoss
-645065
CY2018Q4 us-gaap Profit Loss
ProfitLoss
-501354
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2797385
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2797385
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1922
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2616
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
20000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114454
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114192
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
237779
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
283913
us-gaap Share Based Compensation
ShareBasedCompensation
527230
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7801600
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124346158
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-125551452
CY2019Q4 us-gaap Revenues
Revenues
CY2018Q4 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
us-gaap Share Based Compensation
ShareBasedCompensation
115850
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
390000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7411600
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7801600
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.08
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.06
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.26
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20375
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y292D
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y36D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y292D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
99500
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
80500
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
390000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.26
CY2019Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
34400
CY2019Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
33400
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
100000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
71658
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
13904
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
16350
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-14816653
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-14724006
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13694938
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14076676
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14674598
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14768518
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28804007
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26382778
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28135409
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26021264
CY2019Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28804007
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26382778
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28135409
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26021254

Files In Submission

Name View Source Status
0001079973-20-000092-index-headers.html Edgar Link pending
0001079973-20-000092-index.html Edgar Link pending
0001079973-20-000092.txt Edgar Link pending
0001079973-20-000092-xbrl.zip Edgar Link pending
bion_10q-123119.htm Edgar Link pending
bnet-20191231.xml Edgar Link completed
bnet-20191231.xsd Edgar Link pending
bnet-20191231_cal.xml Edgar Link unprocessable
bnet-20191231_def.xml Edgar Link unprocessable
bnet-20191231_lab.xml Edgar Link unprocessable
bnet-20191231_pre.xml Edgar Link unprocessable
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32x1.htm Edgar Link pending
ex32x2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending